Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Raise $500M Through Senior Notes Offering

NEW YORK – Agilent Technologies said on Monday that it has priced an underwritten, registered public offering of a series of its senior notes, in an aggregate principal amount of $500 million.

In a filing with the US Securities and Exchange Commission, the company said that the notes will mature in June 2030 and will bear interest at an annual rate of 2.1 percent. The offering is expected to close on June 4, and Agilent is expecting net proceeds of about $494.3 million.

The company plans to use the funds from the offering for general corporate purposes, including, together with cash on hand, to repay borrowings under its term loan facility.

Bank of America Securities, Mizuho Securities USA, and Wells Fargo Securities are acting as joint book-running managers.

Agilent's shares were up a fraction of 1 percent to $90.15 in mid-morning trading on the New York Stock Exchange. 

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.